Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Rajer · SciRah

Researcher profile · Semantic Scholar

M. Rajer

Share profile

M. Rajer — researcher profile on SciRah

h-index: 12
Works: 36
Citations: 543

Most-cited papers

Malignant spinal cord compression
M. Rajer, Vilijem Kovac
2008275 citations Open access
Semantic Scholar
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
V. Kovač, M. Zwitter, M. Rajer, A. Marin +3 more
2012Anti-Cancer Drugs38 citations
Semantic Scholar
New Challenges in Communication with Cancer Patients
A. Surbone, M. Zwitter, M. Rajer, R. Stiefel
201333 citations
Semantic Scholar
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations
M. Zwitter, M. Rajer, K. Stanič, M. Vrankar +5 more
2016Cancer Biology & Therapy24 citations Open access
Semantic Scholar
The role of PET-CT in radiotherapy planning of solid tumours
S. Jelerčič, M. Rajer
2015Radiology and Oncology24 citations Open access
Semantic Scholar
Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial
M. Zwitter, V. Kovač, M. Rajer, M. Vrankar +1 more
2010Anti-Cancer Drugs24 citations
Semantic Scholar
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment
A. Agbarya, W. Shalata, A. Addeo, A. Charpidou +8 more
2022Journal of Clinical Medicine22 citations Open access
Semantic Scholar
Pollution in the working place and social status: co-factors in lung cancer carcinogenesis.
M. Rajer, M. Zwitter, B. Rajer
2014Lung Cancer16 citations
Semantic Scholar
Quantitative analysis of fine needle aspiration biopsy samples
M. Rajer, M. Kmet
200516 citations
Semantic Scholar
Care of Patients with Non-small-cell Lung Cancer Stage III – The Central European Real-world Experience
M. Zemanova, R. Pirker, L. Petruželka, Zuzana Zbožínková +22 more
2020Radiology and Oncology15 citations Open access
Semantic Scholar
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations
M. Zwitter, K. Stanič, M. Rajer, I. Kern +3 more
2014Radiology and Oncology15 citations Open access
Semantic Scholar
Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial
M. Zwitter, M. Rajer, V. Kovač, I. Kern +2 more
2011Journal of Biomedicine and Biotechnology12 citations Open access
Semantic Scholar
Budget projections and clinical impact of an immuno-oncology class of treatments: Experience in four EU markets.
B. Rachev, N. Wilking, G. Kobelt, F. Spandonaro +4 more
2021Journal of Cancer Policy8 citations
Semantic Scholar
Cutaneous leukocytoclastic vasculitis in a patient treated with carboplatin for uterine carcinoma
M. Rajer, B. Gregorič, M. Živanović, E. Škof
2021European Journal of Gynaecological Oncology4 citations Open access
Semantic Scholar
Treatment of Renal Cell Carcinoma in Elderly and Frail Patients
M. Rajer
20124 citations Open access
Semantic Scholar
154P CNS response to osimertinib in patients with EGFR mutated lung adenocarcinoma: Real world data
R. Devjak, N. T. Hitij, K. Mohorčič, M. Rajer +1 more
20183 citations Open access
Semantic Scholar
Kidney cancer
M. Rajer
20073 citations Open access
Semantic Scholar
Current Cancer Treatment
M. Rajer, E. Segelov
20202 citations Open access
Semantic Scholar
207P 10-year real-world outcomes with neoadjuvant systemic therapy in non-inflammatory breast cancer
A. Kovač, K. Cankar, L. Dobovišek, L. Cavka +6 more
20201 citations Open access
Semantic Scholar
1683P SARS-CoV-2 infection and lung cancer management in Europe
A. Agbarya, A. Addeo, A. Charpidou, A. Araújo +6 more
2020Annals of Oncology1 citations Open access
Semantic Scholar
Projecting the budget and health impact of PD-1/PD-L1 inhibitors in Slovenia
J. van Bavel, S. Lucherini, M. Rajer, S. Jovanovic +6 more
2018European Journal of Public Health1 citations Open access
Semantic Scholar
P3.03-030 Cisplatin with Pemetrexed or Gemcitabine in Prolonged Infusion for Inoperable Mesothelioma: A Phase II Randomized Trial: Topic: Mesothelioma Clinical
V. Kovač, M. Zwitter, D. Štrbac, K. Goričar +3 more
20171 citations Open access
Semantic Scholar
The Benefits and Pitfalls of the Internet in Communication with Cancer Patients
M. Rajer
20131 citations
Semantic Scholar
Locoregional control and survival after breast conserving therapy
M. Rajer, E. Majdič
20061 citations
Semantic Scholar
Smoking Prevention and Cessation
M. Rajer
20180 citations Open access
Semantic Scholar
YI01b.03 Scientific Mentoring: The Reality
M. Rajer
20170 citations Open access
Semantic Scholar
Prognostic and Predictive Value of PD-L1 in Patients with Lung Cancer
M. Rajer
20170 citations Open access
Semantic Scholar
3008 No benefit of temozolamide added to whole brain radiotherapy for non-small cell lung cancer metastases
M. Rajer, U. Smrdel, M. Zwitter, V. Kovač
20150 citations
Semantic Scholar
1026 Risk of lung cancer among metal and construction workers
M. Rajer, M. Zwitter, B. Rajer
20150 citations
Semantic Scholar
Cancer patients and mass media.
M. Rajer, L. Cavka, Amela Duratović
20150 citations
Semantic Scholar
P23. PET-CT confirms high rate of complete remissions among patients with advanced EGFR positive NSCLC treated with intercalated therapy
M. Zwitter, V. Kovač, K. Stanič, M. Rajer +1 more
20140 citations
Semantic Scholar
P12. Long term treatment with erlotinib in advanced non-small cell lung cancer patients
M. Rajer, M. Zwitter, N. Triller, Vilijem Kovac +1 more
20140 citations
Semantic Scholar
Changing Mechanisms of Action as a Strategy for Sequential Targeted Therapy of Metastatic Renal-Cell Carcinoma
M. Rajer
20130 citations Open access
Semantic Scholar
Lung Cancer in Terms of Occupational and Social Disease
M. Zwitter, M. Rajer, I. Oblak, F. Anderluh +2 more
20100 citations
Semantic Scholar
Local control and survival in breast cancer patients stage I and II after Breast Conserving Treatment (BCT); comparison of two groups
E. Majdič, M. Rajer
20070 citations
Semantic Scholar
Basic Clinical Radiobiology Course Ljubljana (Slovenia), 21.-25. May 2006 View from a local participant
M. Rajer
20070 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Zwitter×13
Invite
M. Zwitter — researcher profile on SciRah
V. Kovač×8
Invite
V. Kovač — researcher profile on SciRah
M. Vrankar×7
Invite
M. Vrankar — researcher profile on SciRah
U. Smrdel×4
Invite
U. Smrdel — researcher profile on SciRah

×4

Invite

I. Kern — researcher profile on SciRah

Invite

K. Stanič — researcher profile on SciRah

Vilijem Kovac×2

Invite

Vilijem Kovac — researcher profile on SciRah

Invite

A. Agbarya — researcher profile on SciRah

Invite

A. Addeo — researcher profile on SciRah

A. Charpidou×2

Invite

A. Charpidou — researcher profile on SciRah

O. Brustugun×2

Invite

O. Brustugun — researcher profile on SciRah

Invite

A. Araújo — researcher profile on SciRah